Published in Am J Physiol Lung Cell Mol Physiol on February 24, 2012
Type IV collagen drives alveolar epithelial-endothelial association and the morphogenetic movements of septation. BMC Biol (2016) 1.42
Postnatal inflammation in the pathogenesis of bronchopulmonary dysplasia. Birth Defects Res A Clin Mol Teratol (2014) 1.08
Pulmonary Hypertension in Preterm Infants with Bronchopulmonary Dysplasia. Pediatr Allergy Immunol Pulmonol (2014) 0.99
Nuclear factor-kappa-B signaling in lung development and disease: one pathway, numerous functions. Birth Defects Res A Clin Mol Teratol (2014) 0.94
Neonatal mice genetically modified to express the elastase inhibitor elafin are protected against the adverse effects of mechanical ventilation on lung growth. Am J Physiol Lung Cell Mol Physiol (2012) 0.94
Small molecular modulation of macrophage migration inhibitory factor in the hyperoxia-induced mouse model of bronchopulmonary dysplasia. Respir Res (2013) 0.89
Understanding the Impact of Infection, Inflammation, and Their Persistence in the Pathogenesis of Bronchopulmonary Dysplasia. Front Med (Lausanne) (2015) 0.88
Disrupted lung development and bronchopulmonary dysplasia: opportunities for lung repair and regeneration. Curr Opin Pediatr (2014) 0.84
Bronchopulmonary dysplasia early changes leading to long-term consequences. Front Med (Lausanne) (2015) 0.82
IκBβ-mediated NF-κB activation confers protection against hyperoxic lung injury. Am J Respir Cell Mol Biol (2014) 0.82
Bronchopulmonary dysplasia - an overview about pathophysiologic concepts. Mol Cell Pediatr (2015) 0.82
Early injury of the neonatal lung contributes to premature lung aging: a hypothesis. Mol Cell Pediatr (2016) 0.82
Resident Endothelial Cells and Endothelial Progenitor Cells Restore Endothelial Barrier Function After Inflammatory Lung Injury. Arterioscler Thromb Vasc Biol (2015) 0.81
Peptides genetically selected for NF-κB activation cooperate with oncogene Ras and model carcinogenic role of inflammation. Proc Natl Acad Sci U S A (2014) 0.81
The genome-wide transcriptional response to neonatal hyperoxia identifies Ahr as a key regulator. Am J Physiol Lung Cell Mol Physiol (2014) 0.80
Pathogenesis of bronchopulmonary dysplasia: when inflammation meets organ development. Mol Cell Pediatr (2016) 0.79
Sustained hyperoxia-induced NF-κB activation improves survival and preserves lung development in neonatal mice. Am J Physiol Lung Cell Mol Physiol (2014) 0.79
Differential sex-specific effects of oxygen toxicity in human umbilical vein endothelial cells. Biochem Biophys Res Commun (2017) 0.77
Vascular mediators in chronic lung disease of infancy: role of endothelial monocyte activating polypeptide II (EMAP II). Birth Defects Res A Clin Mol Teratol (2014) 0.77
Absence of TNF-α enhances inflammatory response in the newborn lung undergoing mechanical ventilation. Am J Physiol Lung Cell Mol Physiol (2016) 0.77
Activation of the nuclear factor-κB pathway during postnatal lung inflammation preserves alveolarization by suppressing macrophage inflammatory protein-2. Am J Physiol Lung Cell Mol Physiol (2015) 0.76
Aberrant Pulmonary Vascular Growth and Remodeling in Bronchopulmonary Dysplasia. Front Med (Lausanne) (2016) 0.75
HIF-1α Plays a Critical Role in the Gestational Sidestream Smoke-Induced Bronchopulmonary Dysplasia in Mice. PLoS One (2015) 0.75
Epithelial-Derived Inflammation Disrupts Elastin Assembly and Alters Saccular Stage Lung Development. Am J Pathol (2016) 0.75
A20 deficiency leads to angiogenesis of pulmonary artery endothelial cells through stronger NF-κB activation under hypoxia. J Cell Mol Med (2016) 0.75
Unique aspects of the developing lung circulation: structural development and regulation of vasomotor tone. Pulm Circ (2016) 0.75
Inhibition of IκBβ/NFκB signaling prevents LPS-induced IL1β expression without increasing apoptosis in the developing mouse lung. Pediatr Res (2017) 0.75
Immunity, inflammation, and cancer. Cell (2010) 28.27
Shared principles in NF-kappaB signaling. Cell (2008) 20.96
Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science (1995) 11.16
Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature (1995) 10.36
Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol (2007) 10.23
Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics (2010) 9.15
Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem (1997) 5.14
Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa B/Rel family. Cell (1995) 4.70
IKKalpha limits macrophage NF-kappaB activation and contributes to the resolution of inflammation. Nature (2005) 4.31
A critical role for NF-kappa B in GATA3 expression and TH2 differentiation in allergic airway inflammation. Nat Immunol (2001) 3.74
Possible new role for NF-kappaB in the resolution of inflammation. Nat Med (2001) 3.53
Reduction of lipofuscin-like autofluorescence in fluorescently labeled tissue. J Histochem Cytochem (1999) 3.18
Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am J Respir Crit Care Med (2001) 3.10
Duration and intensity of NF-kappaB activity determine the severity of endotoxin-induced acute lung injury. J Immunol (2006) 2.96
Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies. J Clin Oncol (2002) 2.88
Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol Lung Cell Mol Physiol (2000) 2.73
An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension. J Clin Invest (2008) 2.71
NF-kappa B RelA-deficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses. J Exp Med (1997) 2.66
NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis. Proc Natl Acad Sci U S A (2004) 2.33
Assessment of air space size characteristics by intercept (chord) measurement: an accurate and efficient stereological approach. J Appl Physiol (1985) (2009) 2.31
Lung function and respiratory symptoms at 11 years in children born extremely preterm: the EPICure study. Am J Respir Crit Care Med (2010) 2.28
Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy. Cancer Sci (2008) 2.12
NF-kappa B and I kappa B alpha: an inducible regulatory system in endothelial activation. J Exp Med (1994) 2.10
Airway epithelium controls lung inflammation and injury through the NF-kappa B pathway. J Immunol (2007) 2.07
Structural aspects of postnatal lung development - alveolar formation and growth. Biol Neonate (2006) 1.96
In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation. J Immunol (1996) 1.96
CXCL8/IL8 stimulates vascular endothelial growth factor (VEGF) expression and the autocrine activation of VEGFR2 in endothelial cells by activating NFkappaB through the CBM (Carma3/Bcl10/Malt1) complex. J Biol Chem (2008) 1.93
NF-kappaB activity in transgenic mice: developmental regulation and tissue specificity. Development (1996) 1.89
Alveoli increase in number but not size from birth to adulthood in rhesus monkeys. Am J Physiol Lung Cell Mol Physiol (2007) 1.86
The transcription factor NF-kappa B and the regulation of vascular cell function. Arterioscler Thromb Vasc Biol (2000) 1.84
Inhibition of constitutive NF-kappa B activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis. J Immunol (2003) 1.83
Cloning and functional analysis of the promoter for KDR/flk-1, a receptor for vascular endothelial growth factor. J Biol Chem (1995) 1.78
An antiinflammatory role for IKKbeta through the inhibition of "classical" macrophage activation. J Exp Med (2008) 1.77
Ineffectiveness of histone deacetylase inhibitors to induce apoptosis involves the transcriptional activation of NF-kappa B through the Akt pathway. J Biol Chem (2003) 1.73
Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure. Am J Physiol Lung Cell Mol Physiol (2002) 1.73
Overexpression of Ref-1 inhibits hypoxia and tumor necrosis factor-induced endothelial cell apoptosis through nuclear factor-kappab-independent and -dependent pathways. Circ Res (2001) 1.70
The radial alveolar count method of Emery and Mithal: a reappraisal 1--postnatal lung growth. Thorax (1982) 1.69
Heme oxygenase-1-derived carbon monoxide requires the activation of transcription factor NF-kappa B to protect endothelial cells from tumor necrosis factor-alpha-mediated apoptosis. J Biol Chem (2002) 1.68
Inhibition of NF-kappa B activity by thalidomide through suppression of IkappaB kinase activity. J Biol Chem (2001) 1.63
Emphysema in young adult survivors of moderate-to-severe bronchopulmonary dysplasia. Eur Respir J (2008) 1.55
Modulation of inducible nitric oxide synthase by hypoxia in pulmonary artery endothelial cells. Am J Respir Cell Mol Biol (2002) 1.55
Postnatal development of alveoli. Regulation and evidence for a critical period in rats. J Clin Invest (1985) 1.51
Constitutive NF-kappaB activation in colorectal carcinoma plays a key role in angiogenesis, promoting tumor growth. Clin Cancer Res (2009) 1.49
Tie2-mediated loss of peroxisome proliferator-activated receptor-gamma in mice causes PDGF receptor-beta-dependent pulmonary arterial muscularization. Am J Physiol Lung Cell Mol Physiol (2009) 1.47
Developmental alveolarization of the mouse lung. Dev Dyn (2008) 1.41
NF-kappaB is a key mediator of cerebral aneurysm formation. Circulation (2007) 1.39
Maturational differences in lung NF-kappaB activation and their role in tolerance to hyperoxia. J Clin Invest (2004) 1.35
NF-kappaB inhibitors for the treatment of inflammatory diseases and cancer. Curr Med Chem (2007) 1.34
Cell-free pool of CD14 mediates activation of transcription factor NF-kappa B by lipopolysaccharide in human endothelial cells. Proc Natl Acad Sci U S A (1993) 1.32
Development and cancer: at the crossroads of Nodal and Notch signaling. Cancer Res (2009) 1.30
The role of nuclear factor kappa B in the pathogenesis of pulmonary diseases: implications for therapy. Am J Respir Med (2003) 1.27
Enalapril protects mice from pulmonary hypertension by inhibiting TNF-mediated activation of NF-kappaB and AP-1. Am J Physiol Lung Cell Mol Physiol (2002) 1.25
Genistein prevents nuclear factor-kappa B activation and acute lung injury induced by lipopolysaccharide. Am J Respir Crit Care Med (2001) 1.23
E-selectin expression in human endothelial cells by TNF-alpha-induced oxidant generation and NF-kappaB activation. Am J Physiol (1998) 1.20
A nuclear factor-kappaB inhibitor pyrrolidine dithiocarbamate ameliorates pulmonary hypertension in rats. Chest (2007) 1.19
Rho/Rho-kinase pathway contributes to C-reactive protein-induced plasminogen activator inhibitor-1 expression in endothelial cells. Arterioscler Thromb Vasc Biol (2005) 1.13
NF-kappaB regulatory mechanisms in alveolar macrophages from patients with acute respiratory distress syndrome. Shock (2000) 1.11
Calcium-dependent regulation of NF-(kappa)B activation in cystic fibrosis airway epithelial cells. Cell Signal (2005) 1.09
The contribution of NF-kappa B activity to spontaneous proliferation and resistance to apoptosis in human T-cell leukemia virus type 1 Tax-induced tumors. Blood (2001) 1.07
Nuclear factor-kappaB activation in neonatal mouse lung protects against lipopolysaccharide-induced inflammation. Am J Respir Crit Care Med (2007) 1.07
Depletion of beta-arrestin-2 promotes tumor growth and angiogenesis in a murine model of lung cancer. J Immunol (2008) 1.05
Regulation of alveologenesis: clinical implications of impaired growth. Pathology (2008) 1.05
Lysophospholipids increase ICAM-1 expression in HUVEC through a Gi- and NF-kappaB-dependent mechanism. Am J Physiol Cell Physiol (2004) 1.04
Characterization of the endothelium-specific murine vascular endothelial growth factor receptor-2 (Flk-1) promoter. Circ Res (1996) 1.03
Angiogenesis in chronic lung disease. Chest (2007) 1.03
NF-kappa B mediates up-regulation of CFTR gene expression in Calu-3 cells by interleukin-1beta. J Biol Chem (2000) 0.99
IKKβ regulates essential functions of the vascular endothelium through kinase-dependent and -independent pathways. Nat Commun (2011) 0.99
Reduced collagen biosynthesis is the hallmark of cerebral aneurysm: contribution of interleukin-1beta and nuclear factor-kappaB. Arterioscler Thromb Vasc Biol (2009) 0.95
NF-kB induces lung maturation during mouse lung morphogenesis. Dev Dyn (2008) 0.92
IkappaB kinase-alpha regulates endothelial cell motility and tumor angiogenesis. Cancer Res (2008) 0.88
Participation of the PI-3K/Akt-NF-kappa B signaling pathways in hypoxia-induced mitogenic factor-stimulated Flk-1 expression in endothelial cells. Respir Res (2006) 0.87
Inhibition of bovine endothelial cell activation in vitro by regulated expression of a transdominant inhibitor of NF-kappa B. J Clin Invest (1997) 0.86
Spatiotemporal expression of flk-1 in pulmonary epithelial cells during lung development. Am J Respir Cell Mol Biol (2008) 0.85
Essential role for platelet-activating factor-induced NF-kappaB activation in macrophage-derived angiogenesis. Eur J Immunol (2004) 0.84
Effects of postnatal dexamethasone treatment on development of alveoli in adult rats. Exp Lung Res (1989) 0.80
Use of genetically altered mice to investigate the role of nuclear factor-kappa B activation and cytokine gene expression in sepsis-induced ARDS. Chest (1999) 0.80
Predisposition of infants with chronic lung disease to respiratory syncytial virus-induced respiratory failure: a vascular hypothesis. Pediatr Infect Dis J (2004) 0.78
Temporal response of the human virome to immunosuppression and antiviral therapy. Cell (2013) 2.72
An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension. J Clin Invest (2008) 2.71
The flowering time regulator CONSTANS is recruited to the FLOWERING LOCUS T promoter via a unique cis-element. New Phytol (2010) 2.63
Autophagic protein LC3B confers resistance against hypoxia-induced pulmonary hypertension. Am J Respir Crit Care Med (2010) 1.93
Mechanical ventilation uncouples synthesis and assembly of elastin and increases apoptosis in lungs of newborn mice. Prelude to defective alveolar septation during lung development? Am J Physiol Lung Cell Mol Physiol (2007) 1.91
Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt-beta-catenin and Wnt-RhoA-Rac1 pathways. J Cell Biol (2009) 1.77
Myeloperoxidase deficiency enhances inflammation after allogeneic marrow transplantation. Am J Physiol Lung Cell Mol Physiol (2004) 1.68
Brain abnormalities, defective meiotic chromosome synapsis and female subfertility in HSF2 null mice. EMBO J (2002) 1.48
Embedding time-limited laboratory orders within computerized provider order entry reduces laboratory utilization. Pediatr Crit Care Med (2013) 1.43
Quantitative analysis of the human airway microbial ecology reveals a pervasive signature for cystic fibrosis. Sci Transl Med (2012) 1.40
Inhaled β2-Agonist Therapy Increases Functional Residual Capacity in Mechanically Ventilated Children With Respiratory Failure. Pediatr Crit Care Med (2015) 1.40
A rose by any other name is yet a rose: acute respiratory failure in children. Am J Respir Crit Care Med (2003) 1.40
The unexpected effect of cyclosporin A on CD56+CD16- and CD56+CD16+ natural killer cell subpopulations. Blood (2007) 1.39
Utility of blood cultures in postoperative pediatric intensive care unit patients. Pediatr Crit Care Med (2009) 1.38
Chronic lung disease in the preterm infant. Lessons learned from animal models. Am J Respir Cell Mol Biol (2014) 1.28
Wnt5a is required for cardiac outflow tract septation in mice. Pediatr Res (2007) 1.27
Prolonged mechanical ventilation with air induces apoptosis and causes failure of alveolar septation and angiogenesis in lungs of newborn mice. Am J Physiol Lung Cell Mol Physiol (2009) 1.27
miR-29b participates in early aneurysm development in Marfan syndrome. Circ Res (2011) 1.22
BMP promotes motility and represses growth of smooth muscle cells by activation of tandem Wnt pathways. J Cell Biol (2011) 1.16
Kruppel-like transcription factor 13 regulates T lymphocyte survival in vivo. J Immunol (2007) 1.16
A comparison of echocardiography to invasive measurement in the evaluation of pulmonary arterial hypertension in a rat model. Int J Cardiovasc Imaging (2010) 1.11
Granulysin, a cytolytic molecule, is also a chemoattractant and proinflammatory activator. J Immunol (2005) 1.10
S100A4 and bone morphogenetic protein-2 codependently induce vascular smooth muscle cell migration via phospho-extracellular signal-regulated kinase and chloride intracellular channel 4. Circ Res (2009) 1.04
Extubation failure in pediatric intensive care incidence and outcomes. Pediatr Crit Care Med (2005) 1.03
Reduced BMPR2 expression induces GM-CSF translation and macrophage recruitment in humans and mice to exacerbate pulmonary hypertension. J Exp Med (2014) 1.01
Whole-exome sequencing reveals TopBP1 as a novel gene in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med (2014) 0.99
Granulysin-mediated tumor rejection in transgenic mice. J Immunol (2007) 0.98
A novel apoptosis pathway activated by the carboxyl terminus of p21. Blood (2004) 0.96
Ferret badger rabies origin and its revisited importance as potential source of rabies transmission in Southeast China. BMC Infect Dis (2010) 0.94
Computerized physician order entry with decision support decreases blood transfusions in children. Pediatrics (2011) 0.91
Neutrophil elastase is produced by pulmonary artery smooth muscle cells and is linked to neointimal lesions. Am J Pathol (2011) 0.91
Contribution of the K(Ca) channel to membrane potential and O2 sensitivity is decreased in an ovine PPHN model. Am J Physiol Lung Cell Mol Physiol (2002) 0.90
Loss of bone morphogenetic protein receptor 2 is associated with abnormal DNA repair in pulmonary arterial hypertension. Am J Respir Cell Mol Biol (2014) 0.90
Hypoxia-inducible factor-1α regulates KCNMB1 expression in human pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol (2011) 0.89
Hypoxia-inducible factor-1α in pulmonary artery smooth muscle cells lowers vascular tone by decreasing myosin light chain phosphorylation. Circ Res (2013) 0.89
Oxygen tension modulates the expression of pulmonary vascular BKCa channel alpha- and beta-subunits. Am J Physiol Lung Cell Mol Physiol (2005) 0.89
Chronic intrauterine pulmonary hypertension selectively modifies pulmonary artery smooth muscle cell gene expression. Am J Physiol Lung Cell Mol Physiol (2006) 0.88
Developmental regulation of hypoxia-inducible factor 1 and prolyl-hydroxylases in pulmonary vascular smooth muscle cells. Proc Natl Acad Sci U S A (2007) 0.88
Chronic intrauterine pulmonary hypertension compromises fetal pulmonary artery smooth muscle cell O2 sensing. Am J Physiol Lung Cell Mol Physiol (2003) 0.87
Risk factors for persistent pulmonary hypertension of the newborn. Pulm Circ (2012) 0.86
Interactive effects of high-frequency oscillatory ventilation and inhaled nitric oxide in acute hypoxemic respiratory failure in pediatrics. Crit Care Med (2002) 0.86
Natural history of pulmonary complications in children after bone marrow transplantation. Biol Blood Marrow Transplant (2005) 0.85
LC3-mediated fibronectin mRNA translation induces fibrosarcoma growth by increasing connective tissue growth factor. J Cell Sci (2009) 0.85
The Accreditation Council for Graduate Medical Education proposed work hour regulations. Pediatr Crit Care Med (2011) 0.85
Expanding the phenotype of Timothy syndrome type 2: an adolescent with ventricular fibrillation but normal development. Am J Med Genet A (2015) 0.85
Disrupted lung development and bronchopulmonary dysplasia: opportunities for lung repair and regeneration. Curr Opin Pediatr (2014) 0.84
Rho kinase modulates postnatal adaptation of the pulmonary circulation through separate effects on pulmonary artery endothelial and smooth muscle cells. Am J Physiol Lung Cell Mol Physiol (2010) 0.83
Lung specific developmental expression of the Xenopus laevis surfactant protein C and B genes. Gene Expr Patterns (2006) 0.83
Role of integrin switch and transforming growth factor Beta 3 in hypoxia-induced invasion inhibition of human extravillous trophoblast cells. Biol Reprod (2012) 0.82
Voltage-dependent anion channel-2 interaction with nitric oxide synthase enhances pulmonary artery endothelial cell nitric oxide production. Am J Respir Cell Mol Biol (2012) 0.82
Acute normoxia increases fetal pulmonary artery endothelial cell cytosolic Ca2+ via Ca2+-induced Ca2+ release. Pediatr Res (2006) 0.82
Chronic intrauterine pulmonary hypertension increases capacitative calcium entry in fetal pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol (2006) 0.82
Oxygen increases ductus arteriosus smooth muscle cytosolic calcium via release of calcium from inositol triphosphate-sensitive stores. Am J Physiol Lung Cell Mol Physiol (2005) 0.81
The EBAX-type Cullin-RING E3 ligase and Hsp90 guard the protein quality of the SAX-3/Robo receptor in developing neurons. Neuron (2013) 0.81
Inhibition of transforming growth factor β worsens elastin degradation in a murine model of Kawasaki disease. Am J Pathol (2011) 0.80
Inflammatory cytokines and the development of pulmonary complications after allogeneic hematopoietic cell transplantation in patients with inherited metabolic storage disorders. Biol Blood Marrow Transplant (2006) 0.79
Use of electronic medical record-enhanced checklist and electronic dashboard to decrease CLABSIs. Pediatrics (2014) 0.79
Therapeutic potential of thymosin β4 in myocardial infarct and heart failure. Ann N Y Acad Sci (2012) 0.78
GATA4 is a key regulator of steroidogenesis and glycolysis in mouse Leydig cells. Endocrinology (2015) 0.78
DQ 65-79, a peptide derived from HLA class II, mimics p21 to block T cell proliferation. J Immunol (2003) 0.77
Case-series of nurse-administered nitrous oxide for urinary catheterization in children. Anesth Analg (2007) 0.77
Epidemic and maintenance of rabies in Chinese ferret badgers (Melogale moschata) indicated by epidemiology and the molecular signatures of rabies viruses. Virol Sin (2013) 0.77
[Clinical significance of detection of cathepsin X and cystatin C in the sera of patients with lung cancer]. Zhongguo Fei Ai Za Zhi (2013) 0.77
[Inhibitory effect of ¹³¹I-CD133mAb combined with cisplatin on liver cancer cells in vitro and in a tumor-bearing mouse model]. Nan Fang Yi Ke Da Xue Xue Bao (2014) 0.76
Pediatric lung transplantation: promise being realized. Curr Opin Pediatr (2014) 0.76
Pulmonary hypertension in the premature infant: a challenging comorbidity in a vulnerable population. Curr Opin Pediatr (2016) 0.75
[Long-term results of postoperative electronic irradiation for 53 patients with keloids]. Zhonghua Zheng Xing Wai Ke Za Zhi (2014) 0.75
[Not Available]. Duodecim (2007) 0.75
Headspace single drop and hollow fiber liquid phase microextractions for HPLC determination of phenols. J Sep Sci (2008) 0.75
DQ 65-79, a peptide derived from HLA class II, induces I kappa B expression. J Immunol (2002) 0.75
The evolution of disease: chronic lung disease of infancy and pulmonary hypertension. Curr Opin Pediatr (2017) 0.75
[Novel high-throughput sequencing strategies in genetic diagnostics]. Duodecim (2013) 0.75
[Amphotericin B suppresses migration and invasion of esophageal carcinoma Eca109 cells in hypoxic microenvironment by down-regulating hypoxia-inducible factor-1α activity]. Nan Fang Yi Ke Da Xue Xue Bao (2014) 0.75